发明授权
US06277863B1 Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes 失效
用于产生凝血酶抑制剂和内源性载体的新型缀合物的方法和组合物,导致具有延长的使用寿命的抗血栓素

  • 专利标题: Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
  • 专利标题(中): 用于产生凝血酶抑制剂和内源性载体的新型缀合物的方法和组合物,导致具有延长的使用寿命的抗血栓素
  • 申请号: US09599379
    申请日: 2000-06-22
  • 公开(公告)号: US06277863B1
    公开(公告)日: 2001-08-21
  • 发明人: Alexander KrantzAlan M. EzrinYonghong Song
  • 申请人: Alexander KrantzAlan M. EzrinYonghong Song
  • 主分类号: A01N4342
  • IPC分类号: A01N4342
Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
摘要:
Novel compounds comprising chemically reactive intermediates which can react with available reactive functionalities on blood components to form covalent linkages, where the resulting covalently-bound conjugates are found to have thrombin inhibition activity are provided. Specifically, the thrombin inhibitor compounds of the present invention are derivatives of the known thrombin inhibitor argatroban, which can be covalently linked to chemically reactive functionalities on various blood components. The conjugated thrombin inhibitors thereby have extended lifetimes in the bloodstream, as compared to the unconjugated parent drug, and are, therefore, capable of maintaining thrombin inhibitory activity for extended periods of time as compared to the unconjugated parent drug. Also provided herein are methods for inhibiting thrombin activity in vivo comprising administering to the bloodstream of a mammalian host the novel compounds of the present invention.
信息查询
0/0